PMID: 20647686Jul 22, 2010Paper

Auranofin, a gold(I)-containing antirheumatic compound, activates Keap1/Nrf2 signaling via Rac1/iNOS signal and mitogen-activated protein kinase activation

Journal of Pharmacological Sciences
Nam-Hoon KimIn-Sook Kim

Abstract

Auranofin (2,3,4,6-tetra-O-acetyl-1-thio-beta-D-glucopyranosato-S-[triethylphosphine] gold) is a gold(I)-containing antirheumatic drug that possesses anti-inflammatory properties. The pharmacological activity of this drug is associated with its ability to induce heme oxygenase-1 (HO-1). However, the mechanism underlying auranofin-mediated HO-1 induction remains unclear. We investigated the action of auranofin on activation of nuclear factor erythroid 2-related factor 2 (Nrf2), an activator of HO-1. Auranofin elevated cellular levels of Nrf2 by increasing protein stability but not transcriptional activation. Coimmunoprecipitation and Western blot analysis indicated that auranofin inhibited Nrf2 degradation by inducing the dissociation of the Nrf2 / Kelch-like ECH-associated protein 1 (Keap1) complex, which resulted in nuclear accumulation of Nrf2. In addition, auranofin treatment activated cellular Rac1 and induced inducible nitric oxide synthase (iNOS) expression. An inhibitor of Rac1 (NSC23766) blocked the iNOS induction as well as Nrf2 activation and HO-1 expression. N(G)-nitro-L-arginine methyl ester and aminoguanidine, inhibitors of iNOS, diminished the auranofin-induced Nrf2 activation and HO-1 expression. Phosphorylation ...Continue Reading

References

Dec 1, 1990·Baillière's Clinical Rheumatology·G D ChampionJ B Ziegler
Sep 15, 1999·Genes & Development·K Itoh, S Y Sokol
May 23, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·K I JeonD M Jue
May 20, 2003·Experimental & Molecular Medicine·Kye-Im JeonDae-Myung Jue
Jul 15, 2003·The Journal of Biological Chemistry·Danielle MorseAugustine M K Choi
Oct 17, 2003·Current Drug Targets. Inflammation and Allergy·Masamichi YamashitaMotoaki Takayanagi
Feb 7, 2004·Proceedings of the National Academy of Sciences of the United States of America·Moon-Il KangMasayuki Yamamoto
Aug 9, 2005·British Journal of Pharmacology·Seon-Joo Park, In-Sook Kim
Mar 31, 2006·Arthritis and Rheumatism·Hideo KobayashiYoshiaki Ishigatsubo
Apr 6, 2006·The Journal of Clinical Investigation·Rajesh K ThimmulappaShyam Biswal
Sep 14, 2006·Annual Review of Pharmacology and Toxicology·Thomas W KenslerShyam Biswal
Oct 13, 2006·Biochemical and Biophysical Research Communications·Hyung S YounDaniel H Hwang
Sep 8, 2007·Antioxidants & Redox Signaling·Cheng LiRoland Stocker
Dec 8, 2007·Free Radical Biology & Medicine·Barbara J BuckleyA Richard Whorton
Jan 19, 2008·Blood·Stuart A Rushworth, David J MacEwan
Jun 21, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Nadia G InnamoratoAntonio Cuadrado
Nov 5, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Stuart A RushworthMaria A O'Connell
Feb 3, 2009·The Journal of Biological Chemistry·Truyen NguyenCecil B Pickett
Apr 11, 2009·Current Opinion in Neurology·Nadia G InnamoratoAntonio Cuadrado
Aug 12, 2009·Biochemical Pharmacology·Valentina GandinCristina Marzano
Aug 27, 2009·Proceedings of the National Academy of Sciences of the United States of America·Chun-Qi LiGerald N Wogan

❮ Previous
Next ❯

Citations

Feb 18, 2014·International Immunopharmacology·Yoshiaki NishioXiao-Kang Li
Feb 1, 2011·Antioxidants & Redox Signaling·Ute JungwirthPetra Heffeter
Sep 12, 2012·Inflammopharmacology·J M MadeiraA Klegeris
Feb 18, 2016·Oxidative Medicine and Cellular Longevity·Christine A HoughtonJeff S Coombes
Nov 20, 2015·Redox Biology·Trent A C NewmanJulia A Horsfield
May 3, 2012·Medicinal Research Reviews·Sadagopan MageshLongqin Hu
Jun 11, 2015·Antioxidants & Redox Signaling·Marcus CebulaElias S J Arnér
Oct 20, 2011·The Journal of Toxicological Sciences·Takashi AshinoTakemi Yoshida
Apr 30, 2014·Metallomics : Integrated Biometal Science·Pavlo HolenyaStefan Wölfl
May 8, 2014·Science Progress·Ruth J McQuitty
Apr 25, 2014·The Journal of Biological Chemistry·Antonio CuadradoIsabel Lastres-Becker
Feb 2, 2015·Chemical Science·Chung-Hang LeungDik-Lung Ma
May 5, 2018·BMC Cancer·Hong ZhangDouglas H Thamm
Mar 31, 2018·Oncotarget·Stephen HyterAndrew K Godwin
Feb 8, 2021·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Pengfei TangLingyi Kong
Nov 30, 2018·Chemical Reviews·Bernhard EnglingerWalter Berger

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.